Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Feb 10, 2016 at 12:15 PM EST

Proteostasis Therapeutics Closes in on IPO

Proteostasis Therapeutics expects to price less than 4 million shares in the range of $12 to $14 apiece in an…

Paul Ausick | Feb 10, 2016 at 11:25 AM EST

Humana Outlook Raises Share Price After Earnings

Humana reported mixed fourth-quarter and full-year 2015 results before markets opened Wednesday morning.

Chris Lange | Feb 10, 2016 at 9:15 AM EST

Short Sellers Increase Bets in Major Pharma

The January 29 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

Chris Lange | Feb 10, 2016 at 8:40 AM EST

Major Biotech Short Interest Continues to Be Mixed

The January 29 short interest data have been compared with the previous report, and short interest was mixed in most…

Chris Lange | Feb 9, 2016 at 12:35 PM EST

Adaptimmune Receives Breakthrough Designation From FDA

Adaptimmune Therapeutics has announced that the FDA granted a Breakthrough Therapy designation for the company's affinity enhanced T-cell therapy.

Chris Lange | Feb 9, 2016 at 12:15 PM EST

Cerus Announces New Partnership With Red Cross

Cerus led the bulls in Tuesday’s trading session on news of a new partnership with one of the biggest charities…

Chris Lange | Feb 9, 2016 at 11:35 AM EST

Why Merrill Lynch Sees Big Upside in Pfizer (and Even More With Allergan)

Merrill Lynch has decided to add Pfizer as its new top pick for 2016. The firm reiterated a Buy rating…

Chris Lange | Feb 9, 2016 at 9:05 AM EST

Regeneron Falls on Missed Earnings

Regeneron Pharmaceuticals reported disappointing fourth-quarter financial results before the markets opened on Tuesday.

Paul Ausick | Feb 8, 2016 at 1:40 PM EST

What to Expect From Centene Earnings

Health insurance provider Centene is scheduled to report fourth-quarter earnings on Tuesday morning before markets open.

Jon C. Ogg | Feb 8, 2016 at 11:05 AM EST

Is BioCryst Reaching Crush Depth?

BioCryst Pharmaceuticals shares were crushed after it announced results from OPuS-2 for the treatment of hereditary angioedema attacks.

Lee Jackson | Feb 8, 2016 at 8:25 AM EST

4 Big Dividend Pharmaceutical Stocks to Buy That Are Very Cheap Now

If you ever want to look for value in a sector in the stock market, then when you see Congress…

Chris Lange | Feb 7, 2016 at 10:15 AM EST

How Analysts View Pfizer and Merck After Earnings

After Pfizer and Merck released their most recent earnings reports last week, analysts weighed in on both of these pharmaceutical…

Chris Lange | Feb 6, 2016 at 10:50 AM EST

How Analysts Value Gilead Now After Earnings

After Gilead Sciences reported fourth-quarter financial results on Tuesday, analysts weighed in on this biotech giant and in what direction…

Chris Lange | Feb 6, 2016 at 10:15 AM EST

Top 4 BioPharma Movers of the Week

Over the past week, Alere and a few biotech other companies made absolutely massive runs, either up and down.

Chris Lange | Feb 5, 2016 at 12:05 PM EST

Party City and Staples Partner Up in E-Commerce Deal

Party City has announced an e-commerce fulfillment relationship with Staples to expand into the e-commerce space.

1 … 223 224 225 226 227 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Proteostasis Therapeutics Closes in on IPO

Humana Outlook Raises Share Price After Earnings

Short Sellers Increase Bets in Major Pharma

Major Biotech Short Interest Continues to Be Mixed

Adaptimmune Receives Breakthrough Designation From FDA

Cerus Announces New Partnership With Red Cross

Why Merrill Lynch Sees Big Upside in Pfizer (and Even More With Allergan)

Regeneron Falls on Missed Earnings

What to Expect From Centene Earnings

Is BioCryst Reaching Crush Depth?

4 Big Dividend Pharmaceutical Stocks to Buy That Are Very Cheap Now

How Analysts View Pfizer and Merck After Earnings

How Analysts Value Gilead Now After Earnings

Top 4 BioPharma Movers of the Week

Party City and Staples Partner Up in E-Commerce Deal

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

Health and Healthcare Articles

All Health and Healthcare Articles

Proteostasis Therapeutics Closes in on IPO

Humana Outlook Raises Share Price After Earnings

Short Sellers Increase Bets in Major Pharma

Major Biotech Short Interest Continues to Be Mixed

Adaptimmune Receives Breakthrough Designation From FDA

Cerus Announces New Partnership With Red Cross

Why Merrill Lynch Sees Big Upside in Pfizer (and Even More With Allergan)

Regeneron Falls on Missed Earnings

What to Expect From Centene Earnings

Is BioCryst Reaching Crush Depth?

4 Big Dividend Pharmaceutical Stocks to Buy That Are Very Cheap Now

How Analysts View Pfizer and Merck After Earnings

How Analysts Value Gilead Now After Earnings

Top 4 BioPharma Movers of the Week

Party City and Staples Partner Up in E-Commerce Deal

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

Featured Reads

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation